company background image
603858 logo

Shandong Buchang Pharmaceuticals XSSC:603858 Stock Report

Last Price


Market Cap







23 Jul, 2024


Company Financials

Shandong Buchang Pharmaceuticals Co., Ltd.

XSSC:603858 Stock Report

Market Cap: CN¥16.6b

603858 Stock Overview

Shandong Buchang Pharmaceuticals Co., Ltd.

603858 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health4/6

Shandong Buchang Pharmaceuticals Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shandong Buchang Pharmaceuticals
Historical stock prices
Current Share PriceCN¥15.12
52 Week HighCN¥20.73
52 Week LowCN¥14.15
11 Month Change-3.20%
3 Month Change-10.59%
1 Year Change-25.66%
33 Year Change-24.85%
5 Year Change-24.72%
Change since IPO-65.18%

Recent News & Updates

Recent updates

Shareholder Returns

603858CN PharmaceuticalsCN Market

Return vs Industry: 603858 underperformed the CN Pharmaceuticals industry which returned -13.4% over the past year.

Return vs Market: 603858 underperformed the CN Market which returned -16.6% over the past year.

Price Volatility

Is 603858's price volatile compared to industry and market?
603858 volatility
603858 Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 603858 has not had significant price volatility in the past 3 months.

Volatility Over Time: 603858's weekly volatility (4%) has been stable over the past year.

About the Company


Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. The company offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. Shandong Buchang Pharmaceuticals Co., Ltd.

Shandong Buchang Pharmaceuticals Co., Ltd. Fundamentals Summary

How do Shandong Buchang Pharmaceuticals's earnings and revenue compare to its market cap?
603858 fundamental statistics
Market capCN¥16.56b
Earnings (TTM)-CN¥22.28m
Revenue (TTM)CN¥12.37b


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603858 income statement (TTM)
Cost of RevenueCN¥4.35b
Gross ProfitCN¥8.02b
Other ExpensesCN¥8.04b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 28, 2024

Earnings per share (EPS)-0.02
Gross Margin64.83%
Net Profit Margin-0.18%
Debt/Equity Ratio32.5%

How did 603858 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.